Dalian Shengya had a daily limit in the afternoon, and its share price hit a record high. Since November, its cumulative increase has exceeded 150%.Wang Tao of UBS: It is estimated that deficit ratio will approach 4% of its financial resources or increase its investment in social security medical care next year. Wang Tao, head of Asian economic research and chief China economist of UBS, said that China's fiscal deficit ratio is expected to approach 4% next year, and the scale of ultra-long-term special government bonds excluding capital injection into state-owned banks may be 2 trillion yuan, and the amount of new local government special bonds may be 4.5 trillion to 5 trillion yuan. In fact, the fiscal expansion next year is relatively mild compared with the fiscal stimulus in 2008-2009. Wang Tao believes that next year, the government will increase investment in social security and medical care, and establish a more perfect social security system while boosting residents' confidence in the short term.Shaanxi experts took the lead in formulating the first Expert Consensus on Clinical Operation of Micro-apical Surgery in China. Recently, according to the news from the Stomatological Hospital of Air Force Military Medical University, Yu Qing, a professor of dental endodontics in this hospital, led by top experts from more than 10 well-known domestic hospitals, including Peking University Stomatological Hospital, West China Stomatological Hospital of Sichuan University and Ninth People's Hospital affiliated to Shanghai Jiaotong University School of Medicine, successfully formulated the first Expert Consensus on Clinical Operation of Micro-apical Surgery in China in three years.
CMB International: Upgraded the target price of WuXi Bio to HK$ 22.88, optimistic about the company's valuation and performance repair. CMB International published a report, predicting that the US Biosafety Act will fail with high probability, which will help WuXi Bio to achieve continuous performance growth in a relatively stable business environment. With the recovery of global biomedical financing, we are optimistic about the company's valuation and performance repair. According to the report, the NDAA in FY 2025 does not include the Biosafety Act, and the legislation of the Biosafety Act failed with high probability. On December 7, the US Senate and the House Armed Services Committee announced the National Defense Authorization Act (NDAA) for fiscal year 2025, which was finally negotiated by the committees of the two houses. The Biosafety Act was not included in the amendment of NDAA in FY 2025, which means that the Biosafety Act failed to pass the legislative path of joining NDAA. The Biosafety Act can still promote separate legislation, but considering that the window of the current US Congress session is less than two weeks, the Bank believes that the success rate of separate legislation is extremely low. CMB International maintained the "Buy" rating of Yaoming Bio, and its target price rose from HK$ 13.58 to HK$ 22.88. It is estimated that the company's revenue will increase by 7.1%/12.4%/ 13.9% from 2024 to 2026, and its adjusted net profit will increase by 0.8%/11.1%/13.4% respectively.Runjian Co., Ltd. invested and established a number of new energy companies in Guizhou. The enterprise search APP shows that recently, Kaili Qida New Energy Co., Ltd., Kaili Xinsheng New Energy Co., Ltd. and Kaili Shunsheng New Energy Co., Ltd. were established, and their legal representatives are all Wen Feng, with a registered capital of 1 million yuan, and their business scope includes: energy-saving management services; Sales of construction machinery; Technical services for solar power generation; Research and development of wind farm related systems; Sales of wind turbines and parts; Power generation technical services, etc. Enterprise investigation shows that all three companies are indirectly wholly-owned by Runjian.The winning bid rate of China's 2-year treasury bonds was 1.06%, which was 31 basis points lower than last month. The Ministry of Finance of China issued treasury bonds today, and the weighted average winning bid rate of 2-year varieties was 1.06%. The data shows that the bid-winning interest rate is about 31 basis points lower than that when the national debt of the same term was issued in November, the lowest since Bloomberg recorded it in 2004.
Chengdu Luqiao invested in the establishment of a mining company in Inner Mongolia. According to the enterprise survey APP, recently, Harqin Banner Beichenxing Mining Co., Ltd. was established, with Hu Wen as the legal representative and a registered capital of 10 million yuan. Its business scope includes: metal ore sales; Non-metallic minerals and products sales; Manufacturing of nonmetallic mineral products; Mineral processing; Mineral washing and processing; Non-metallic waste and debris processing, etc. Enterprise survey shows that the company is indirectly wholly-owned by Chengdu Luqiao.Zhongkong Technology won the bid for the whole plant control system project of Rong Sheng New Materials and held a kick-off meeting. Recently, Zhongkong Technology successfully won the bid for the whole plant control system framework project of Jintang New Materials Project of Rong Sheng New Materials (Zhoushan) Co., Ltd. (hereinafter referred to as "Jintang New Materials Project") and held a kick-off meeting in Zhongkong Science Park. The project is expected to deploy 360,000-point I/O DCS system, 15,000-point SIS system and 10,000-point GDS system. At the same time, a number of new products and technologies that occupy the forefront of the industry, such as UCS products of central control technology, SmartEIO, million-point real-time database and calorific value analysis, will also be applied on a large scale in this project, helping Jintang new materials to build a world-leading intelligent factory.Huatai Securities: The countercyclical adjustment is stronger than expected, and the expansion of domestic demand may fall on the policy of boosting consumption. Huatai Securities believes that the macro-policy orientation conveyed by the Central Economic Work Conference is more positive, in fiscal policy (expanding deficit, increasing special national debt, expanding the use scope of special debt, etc.), monetary policy (moderately easing, timely lowering the RRR and cutting interest rates), real estate and capital market (stabilizing the property market and stock market), and expanding domestic demand policy (implementing special actions to boost consumption) In terms of currency securities, Huatai Securities believes that there is still room for interest rate cuts. On the one hand, the current real interest rate level is still high in horizontal comparison; On the other hand, credit expansion, especially the balance sheet expansion of developers and local governments, is relatively weak, and the cost of capital has room for further decline. It is expected that the central bank will cut interest rates by 30-50 basis points next year, but the pace may be affected by external changes and exchange rates.
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14